Participation in faecal occult blood screening for colorectal cancer
References (23)
- et al.
Prognostic factors in carcinoma of the colon and rectum
Am. J. Surg.
(1968) - et al.
Assessment of attitudes toward mass screening for colorectal cancer and polyps
Prev. Med.
(1981) - et al.
Motivation to participate in cancer screening programmes
Soc. Sci. Med.
(1979) - et al.
Public knowledge and attitudes on colorectal carcinoma and screening in a New South Wales rural town
Communit. Hlth Stud.
(1978) - et al.
large bowel cancer—the next move?
Med. J. Aust.
(1982) Results of treatment of carcinoma of the colon and rectum
- et al.
Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons
Ann. Surg.
(1978) Screening for colorectal cancer: an overview
Cancer
(1980)- et al.
Progress report on controlled trial of faecal occult blood testing for the detection of colorectal neoplasia
Cancer
(1980) - et al.
Screening for symptomless colorectal cancer by testing for occult blood in general practice
Lancet
(1980)
Hemoccult screening for colorectal neoplasms: report of a pilot project
Wisc. Med. J.
Cited by (51)
Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea
2014, European Journal of Oncology NursingCitation Excerpt :This is also the case among various ethnic groups (e.g., Australians, Chinese–Americans, and the French). Adults have frequently reported worries or fears of positive test results (i.e., indicating cancer) as one of the main reasons for avoiding FOBT (Dent et al., 1983; Sun et al., 2004; Vernon, 1997). Another important issue to consider in this study is the non-significant effects of self-efficacy and perceived benefits.
What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): A qualitative study
2008, Social Science and MedicineCitation Excerpt :Survival rates are higher when the disease is detected early, and screening with the Faecal Occult Blood test (FOBt) can reduce bowel cancer mortality by 16% (Hewitson, Glasziou, Irwig, Towler, & Watson, 2007). Several studies in the United States (Beeker, Kraft, Southwell, & Jorgensen, 2000; O'Malley, Beaton, Yabroff, Abramson, & Mandelblatt, 2004; Wackerbath, Peters, & Haist, 2005), Australia (Clavarino et al., 2004; Dent, Bartrop, Goulston, & Chapuis, 1983; Worthley et al., 2006) and Europe (Rossi et al., 2005) have identified factors that may influence people's decisions about whether to take part in screening for bowel cancer. Research done in other countries can help us to understand why people make screening decisions, but researchers and policy makers should remember that screening strategies elsewhere may differ.
Factors associated with colorectal cancer screening among Chinese-Americans
2004, Preventive MedicineColorectal cancer screening with flexible sigmoidoscopy - Participants' experiences and technical feasibility
2004, European Journal of Surgical OncologyCancer surveillance in ulcerative colitis: Critical analysis of long-term prospective programme
2002, Digestive and Liver Disease